CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Echocardiograms +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02543294
NCT02543294N/ACompleted
CompareCT.gov

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

M.D. Anderson Cancer Center·interventional·Posted Sep 7, 2015·Updated Feb 5, 2020

In Brief

A clinical study evaluating Echocardiograms, Electrocardiogram, and 2 other interventions for Heart Failure and Cancer Treatment Induced Left Ventricular Dysfunction. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Cancer Treatment Induced Left Ventricular Dysfunction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2015
Enrollment StartSep 10, 2012
Primary CompletionSep 10, 2017
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 10.8 years ago

Interventions

Echocardiogramsdevice

Participants undergo echocardiograms with contrast done at baseline and at months 2, 4, 6, 12, 18, and 30.

Electrocardiogramdevice

Electrocardiogram performed at baseline.

Symptom Questionnairebehavioral

Symptom questionnaire completed at baseline and at months 1, 2, 4, 6, 12, 18, and 30.

Telephone Follow-Upbehavioral

Telephone follow-up by study staff at months 3 and 5.